More and more Americans are turning to GLP-1 injections to lose weight. FOX 7 Austin's Rebecca Thomas spoke to an Austin ...

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...

美国食品药品管理局（FDA）批准了首个仿制药Victoza（利拉鲁肽注射液）18毫克/3毫升，这是一种胰高血糖素样肽-1（GLP-1）受体激动剂，用于作为饮食和运动的辅助手段改善成人和10岁及以上儿童2型糖尿病患者的血糖控制。

Telehealth company Hims & Hers Health Inc. (NYSE: HIMS) was already a thriving platform discretely selling doctor-prescribed sexual health treatment along with prescription hair loss and mental ...

The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...

The participants were divided into two groups, with half receiving weekly low-dose injections of semaglutide (Ozempic and Wegovy), a GLP-1 agonist, and the other half getting a placebo shot.

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based medical technology enterprise, was recently approved for market by China's ...